Identification of Atorvastatin for Moderate to Severe Hidradenitis through Drug Repositioning Using Public Gene Expression Datasets

J Invest Dermatol. 2018 May;138(5):1209-1212. doi: 10.1016/j.jid.2017.12.002. Epub 2017 Dec 13.

Authors

Karen Y Kuo¹, Hyunje Grace Cho¹, Kavita Y Sarin²

Affiliations

¹ Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA.
² Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA. Electronic address: ksarin@stanford.edu.

PMID: 29247661
DOI: 10.1016/j.jid.2017.12.002

No abstract available

MeSH terms

Adult
Atorvastatin / therapeutic use*
Datasets as Topic*
Drug Repositioning*
Female
Gene Expression
Hidradenitis / drug therapy*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Male
Middle Aged

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Atorvastatin